Methylphenidate Clinical Trials
17 recruitingDrug
Phase 46Phase 25Phase 13Not Applicable2Phase 31
Showing 1–17 of 17 trials
Recruiting
Not Applicable
Orexin s Role in the Neurobiology of Substance Use Disorder
Nicotine Dependence
National Institute on Drug Abuse (NIDA)140 enrolled1 locationNCT05630781
Recruiting
Phase 1
A Trial to Assess How Centanafadine Interacts With Stimulants in the Body
ADHD
Otsuka Pharmaceutical Development & Commercialization, Inc.42 enrolled1 locationNCT07314333
Recruiting
Phase 2
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
Chronic Neuropathic Pain
Unity Health Toronto40 enrolled1 locationNCT07301632
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Lactating Women on Select DOIBreastfed Infants of Mothers on Select DOI
Duke University1,600 enrolled22 locationsNCT03511118
Recruiting
Phase 4
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
Posttraumatic Stress Disorder (PTSD)
VA Office of Research and Development70 enrolled3 locationsNCT05776056
Recruiting
Phase 2Phase 3
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
CancerDepressionSleep+2 more
M.D. Anderson Cancer Center188 enrolled1 locationNCT05474846
Recruiting
Not Applicable
Oxygen Toxicity: Mechanisms in Humans
SeizuresHypercapniaOxygen Toxicity
Duke University62 enrolled1 locationNCT05761756
Recruiting
Phase 4
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
ADHD - Combined Type
Johns Hopkins University30 enrolled1 locationNCT04781972
Recruiting
Phase 1
Psilocybin in Chronic Low Back Pain and Depression
DepressionChronic Low-back Pain
Johns Hopkins University40 enrolled1 locationNCT06355414
Recruiting
Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder Combined
Donald Gilbert, MD, MS, FAAN, FAAP214 enrolled2 locationsNCT04421248
Recruiting
Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
Epilepsy
VA Office of Research and Development226 enrolled4 locationsNCT04419272
Recruiting
Phase 2
Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
Posttraumatic Stress Disorder
University of Haifa53 enrolled3 locationsNCT05133804
Recruiting
Phase 2
The Role of Brain Dopamine in Chronic Pain
Chronic Pain
University of Rochester10 enrolled1 locationNCT05285683
Recruiting
Phase 2
Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
Diabetes Mellitus, Type 1Attention Deficit Disorder with Hyperactivity
Medical University of Lodz150 enrolled1 locationNCT05957055
Recruiting
Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Attention Deficit Hyperactivity DisorderADHD
Icahn School of Medicine at Mount Sinai44 enrolled1 locationNCT03781765
Recruiting
Phase 4
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Attention Deficit Hyperactivity DisorderADHD
Icahn School of Medicine at Mount Sinai500 enrolled4 locationsNCT03781752
Recruiting
Phase 1
Differences by Sex and Genotype in the Effects of Stress on Executive Functions
Stress
University of British Columbia146 enrolled1 locationNCT04273880